Anti-IL1RAP/CD3 Bispecific Antibody (BsAb) Is a Promising Novel and Effective Therapy for Acute Myeloid Leukemia (AML)

被引：0
|
作者：
Meng, Weixu
Del Real, Marissa
Wei, Guowei
Hernandez, Rochelle
Marcucci, Emanuela
Lin, Allen
Mcdonald, Tinisha
Zhao, Dandan
Wu, Herman
Carlesso, Nadia
Kwak, Larry W.
Li, Ling
Kuo, Ya-Huei
Stein, Anthony S.
Pullarkat, Vinod
Nakamura, Ryotaro
Rosen, Steven T.
Forman, Stephen J.
Zhang, Bin
Budde, Lihua
Marcucci, Guido
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1361
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting acute myeloid leukemia via anti-IL1RAP antibodies
    Jiang, Ping
    Liu, Bob Y.
    Huang, Jen
    Lu, Jennifer
    Roy, Sharmili
    Mishra, Madhavi
    Zhao, Xiaoxian
    Lin, Jeffrey
    Hsi, Eric D.
    Junutula, Jagath R.
    CANCER RESEARCH, 2016, 76
  • [2] A Novel Full Length Anti-FLT3 CD3 Bispecific Antibody for the Treatment of Acute Myeloid Leukemia
    Djuretic, Ivana
    Krishnamoorthy, Veena
    Sommer, Cesar
    Dettling, Danielle E.
    Poulsen, Kris
    Chen, Wei
    Hu, Wenyue
    Chunyk, Allison Given
    Lindquist, Kevin
    Potluri, Shobha
    Rickert, Robert C.
    Sasu, Barbra
    Chaparro-Riggers, Javier
    Yeung, Yik Andy
    BLOOD, 2018, 132
  • [3] An anti-CD3/anti-CLL-1 bispecific antibody for the treatment of acute myeloid leukemia
    Leong, Steven R.
    Sukumaran, Siddharth
    Hristopoulos, Maria
    Totpal, Klara
    Stainton, Shannon
    Lu, Elizabeth
    Wong, Alfred
    Tam, Lucinda
    Newman, Robert
    Vuillemenot, Brian R.
    Ellerman, Diego
    Gu, Chen
    Mathieu, Mary
    Dennis, Mark S.
    Nguyen, Allen
    Zheng, Bing
    Zhang, Crystal
    Lee, Genee
    Chu, Yu-Waye
    Prell, Rodney A.
    Lin, Kedan
    Laing, Steven T.
    Polson, Andrew G.
    BLOOD, 2017, 129 (05) : 609 - 618
  • [4] A novel bispecific LILRB4/CD3 antibody with potent killing of monocytic acute myeloid leukemia cells
    Huang, Tao
    Hong, Kyu
    McCutcheon, Krista
    Ma, Jing-Tyan
    Zhu, Ying
    Deng, Mi
    Zhang, Cheng Cheng
    Woodard, Paul
    Xiang, Hong
    Schebye, Xiao Min
    Liao, X. Charlene
    CANCER RESEARCH, 2023, 83 (08)
  • [5] A phase I dose escalating study of infusion of a bispecific antibody (BsAb) for relapsed/refractory acute myeloid leukemia (AML).
    Chen, J
    Bashey, A
    Holman, P
    Carrier, E
    Law, P
    Ball, ED
    BLOOD, 1999, 94 (10) : 227B - 227B
  • [6] Biting Leukemia: CD33/CD3 Bispecific Antibody Constructs for the Treatment of AML
    Subklewe, Marion
    ANNALS OF HEMATOLOGY, 2017, 96 : S46 - S46
  • [7] Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)
    Gaudet, Francois
    Nemeth, Jennifer F.
    McDaid, Ronan
    Li, Yingzhe
    Harman, Benjamin
    Millar, Hillary
    Teplyakov, Alexey
    Wheeler, John
    Luo, Jinquan
    Tam, Susan
    Wu, Sheng-Jiun
    Chen, Emily
    Babich, Alexander
    Elsayed, Yusri
    Attar, Ricardo
    CANCER RESEARCH, 2016, 76
  • [8] An asymmetrical CLL1/CD3 bispecific antibody, ABL602, exhibits CLL1 binding-dependent CD3 binding/activation and antitumor activity in acute myeloid leukemia (AML) mouse model and leukemia blasts from AML patients
    Lee, E.
    Lim, Y.
    Lee, S.
    Park, S.
    Park, H.
    Koh, Y.
    Shin, D.
    Won, J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S828 - S829
  • [9] Preclinical characterization of MT114, a novel CD33/CD3-bispecific BiTE antibody for the treatment of acute myeloid leukemia (AML)
    Henn, Anja
    Friedrich, Matthias
    Kischel, Roman
    Lutterbuese, Ralf
    Schneider, Katja
    Mueller, Peter
    Baeuerle, Patrick A.
    Raum, Tobias
    Kufer, Peter
    Rattel, Benno
    CANCER RESEARCH, 2012, 72
  • [10] Targeting of CLEC12A In Acute Myeloid Leukemia by Antibody-Drug-Conjugates and Bispecific CLL-1 x CD3 BiTE Antibody
    Noordhuis, Paul
    Terwijn, Monique
    Rutten, Arjo P.
    Smit, Linda
    Ossenkoppele, Gert J.
    Schuurhuis, Gerrit J.
    BLOOD, 2010, 116 (21) : 1191 - 1191
12345